ClinConnect ClinConnect Logo
Search / Trial NCT06041347

Learning Curve for the Visualization of Sacral Plexus on TVS

Launched by SEMMELWEIS UNIVERSITY · Sep 14, 2023

Trial Information

Current as of July 24, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well healthcare providers can learn to use a special ultrasound technique called transvaginal ultrasound (TVUS) to see certain nerve structures in the lower back area, specifically the sacral plexus. These nerve structures can be important in diagnosing conditions like endometriosis, nerve sheath tumors, and radiculopathy (which is pain caused by nerve irritation). The goal is to find out how many practice sessions a provider needs to become skilled at this process.

To be part of the study, participants need to be women aged 65 to 74 who are experiencing pelvic pain and are scheduled for a TVUS. Women who are under 18, have never been sexually active, are pregnant, or have certain types of pelvic cancers cannot take part in this trial. Those who participate can expect to undergo a TVUS and help researchers learn how to improve this important diagnostic tool for women's health. The study is currently not recruiting participants yet, but it aims to enhance the understanding of how to effectively use this ultrasound technique.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients with pelvic pain scheduled for TVS
  • Exclusion Criteria:
  • 18 years
  • Women who have never been sexually active
  • (suspected) Pelvic malignancy for example gynecological, intestinal or urological malignancy
  • Premenarche
  • Pregnancy
  • Patients refusal to participate to the study

About Semmelweis University

Semmelweis University, located in Budapest, Hungary, is a prestigious institution renowned for its commitment to advancing medical education, research, and healthcare innovation. As a prominent clinical trial sponsor, the university leverages its extensive expertise in various medical fields to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing therapeutic strategies. With a focus on ethical standards and scientific excellence, Semmelweis University collaborates with a network of healthcare professionals and researchers to translate groundbreaking discoveries into practical applications, ultimately contributing to the global advancement of medical science.

Locations

Budapest, , Hungary

Patients applied

0 patients applied

Trial Officials

Gábor Szabó, PhD

Principal Investigator

Semmelweis University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported